3-Time Colon Cancer Survivor, First Diagnosed at 34, Shares Story
06:50
Jason Benetti Opens up on Inspiring Baseball Path: ‘Do the Work’
04:40
Trader Joe’s Recalls 10M Additional Pounds of Frozen Food
00:25
How to Get More Protein in Your Diet and Why It's Important
05:37
How to Spot the 'Silent' Symptoms of Chronic Inflammation
04:32
Metabolism-Boosting Foods to Add to Your Diet
06:03
Company says they make IVF more accessible through AI-powered fertility care
03:26
NBC Select Wellness Awards: Nike Sneakers, On Socks, More
04:37
Amanda Peet Reveals Breast Cancer Diagnosis in Powerful Essay
05:06
Tips for Finding Relief and Treating Spring Allergies in 2026
02:29
FDA pulls proposed rule banning minors from tanning beds
03:00
Celebrate World Happiness Day With These Simple Hacks
03:51
Bottles of Children’s Ibuprofen Recalled Due to ‘Foreign Substance'
00:30
What You Should Know about New Cholesterol Guidelines for 2026
03:56
Health Screenings Guide: The Tests You Should Get at Every Age
04:33
FDA Links Raw Farm Brand of Cheddar Cheese to 7 E. Coli Cases
00:27
Billy Porter Opens Up on Health Scare, New Children's Book, More
05:11
Fact Vs. Myth: Here's What to Know About Digestive Health
04:42
WH Chief of Staff Susie Wiles Diagnosed With Breast Cancer
02:11
Nightly News
FDA approves first medical treatment for Alzheimer’s in 18 years
This version of Fda Approves First Medical Treatment For Alzheimer S In 18 Years 114445381880 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.
01:30
Copied
The drug aducanumab, developed by the company Biogen, attacks the amyloid protein that builds up in the brain of Alzheimer’s patients. The drug is going on the market even though the FDA says there are “uncertainties regarding clinical benefits” and is requiring Biogen to do another clinical trial.June 7, 2021
